Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

FDA oks mobile app for iPhone, iPad viewing

Calgary Scientific has received FDA clearance to market ResolutionMD Mobile as a mobile diagnostic application in the U.S.

FDA greenlights Eizo's monitor with medical display system

Eizo Nanao Technologies has received FDA 510(k) clearance for its RadiForce LS560W monitor with LMM56800 medical display system for use in interventional radiology and surgical suites.

Sebelius names winners of internal HHS contest

Advancing her initiative to encourage innovation within the Department of Health and Human Services (HHS), Secretary Kathleen Sebelius announced her selection of winners for Round 3 of HHSinnovates Sept. 26.

FDA clears Infinitt's image fusion software

Infinitt North America, a developer of image and information management technologies for healthcare, has received FDA clearance for its fusion software, Xelis Fusion. The software is now available to the North American market.

New OCT system enters European market for peripheral disease

Avinger has received a CE mark for Ocelot, a system that combines the use of its peripheral catheter designs incorporated with optical coherence tomography (OCT) for the treatment of peripheral artery disease (PAD).

NIH deploys PET/MR

The National Institutes of Health (NIH) Clinical Center has begun imaging patients on a whole-body simultaneous PET and MRI device (Siemens Healthcare, Biograph mMR) as a new weapon in its arsenal to diagnose and treat traumatic brain injury and post-traumatic stress disorder among military service members and civilians.

Merits of public-safety regulation presented to Congress

Citing the effectiveness of public safeguards, David Arkush, director of Public Citizens Congress Watch, advocated for reducing barriers to creating healthcare regulations before Congress Committee on Oversight and Government Reform.

Feature: NLST researchers aim to answer cost questions

With preliminary results linking CT screening with a 20 percent decrease in lung cancer mortality compared with chest x-ray, the National Lung Screening Trial (NLST) research team has turned to secondary endpoints of the trial and started to analyze cost data.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.